L
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Price:
4.34
CNY
-2.03%
Market Closed
Market Cap:
¥3.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
CN |
|
Qnb Bank AS
IST:QNBTR.E
|
TR |
|
T
|
Thai Optical Group PCL
SET:TOG
|
TH |
|
Z
|
Zhengzhou Coal Mining Machinery Group Co Ltd
SSE:601717
|
CN |
|
Dynavision Ltd
BSE:517238
|
IN |
|
Rusolovo PAO
MOEX:ROLO
|
RU |
|
S
|
Srivichai vejvivat PCL
SET:VIH
|
TH |
|
S
|
Suncorp Technologies Ltd
HKEX:1063
|
HK |
|
Thunderbird Entertainment Group Inc
XTSX:TBRD
|
CA |
|
Transocean Ltd
NYSE:RIG
|
CH |
|
LS 2 Holdings Ltd
SGX:ENV
|
SG |
|
Jumbo SA
OTC:JUMSY
|
GR |
|
I
|
Interlink Communication PCL
SET:ILINK
|
TH |
Multiples-Based Value
The Multiples-Based Value of one Lionco Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 4.34 CNY, Lionco Pharmaceutical Group Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Lionco Pharmaceutical Group Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Lionco Pharmaceutical Group Co Ltd Competitors
Lionco Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
3.1B CNY | 7.3 | -26.4 | -40.3 | -40.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
